|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 47/68 | (2017.01) |
| (11) | Number of the document | 3710485 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19732174.8 |
| Date of filing the European patent application | 2019-05-30 | |
| (97) | Date of publication of the European application | 2020-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-31 |
| (46) | Date of publication of the claims translation | 2021-05-10 |
| (86) | Number | PCT/US2019/034701 |
| Date | 2019-05-30 |
| (87) | Number | WO 2019/232241 |
| Date | 2019-12-05 |
| (30) | Number | Date | Country code |
| 201862678061 P | 2018-05-30 | US |
| (72) |
LIU, David, US
GAVRILYUK, Julia, US
SCHAMMEL, Alexander, US
|
| (73) |
AbbVie Stemcentrx LLC,
1 North Waukegan Road, North Chicago, Illinois 60064,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-SEZ6 antikūnų vaisto konjugatai ir naudojimo būdai |
| ANTI-SEZ6 ANTIBODY DRUG CONJUGATES AND METHODS OF USE |
| Payment date | Validity (years) | Amount | |
| 2025-04-09 | 7 | 162.00 EUR |
| 2026-05-30 |